Kapok Fertility Clinics Files IPO Prospectus, Aiming to Become China's Largest Reproductive Specialty Chain

“The Three-Child Policy” has further fueled the already booming reproductive health sector.

On the day the policy was announced, the secondary market saw an immediate surge. Stocks of companies such as Aoyang Health, Hybribio, Joint Pharmaceutical Group, International Medical Center, and Yuexin Health rose significantly. Before the market close, the A-share “two-child” concept sector skyrocketed, with Beingmate and Goldlok hitting their daily price limits, while Babybox and David Medical continued to climb sharply.

Such high popularity is inseparable from direct policy guidance, but even more so from the positive incentives driven by enormous market demand. In late May this year, Qiao Jie, Dean of Peking University Third Hospital, an academician of the Chinese Academy of Engineering, and a renowned expert in reproductive medicine, mentioned in a report published in The Lancet that IChina's infertility rate rose from 12% in 2007 to 15% in 2010, and further to approximately 18% in 2020. Based on population proportions, the number of individuals affected by infertility in China has exceeded 10 million.

It is evident that the demand for diagnosis and treatment of infertility is substantial, yet it presents significant challenges. In particular, reproductive centers or specialized reproductive care chains must emerge as “leaders” in this field to secure their position in a highly competitive market. Therefore, both “professionalism” and “service” are indispensable, and Woodpecker Doctors exemplify these two core elements.

Established in 2017, the Mumu Flower Reproductive Specialty Chain Clinics has been committed to providing patients with reproductive disorders with "professional, humanized, and individualized" diagnostic and treatment services, with overall pricing levels comparable to those of Grade A tertiary hospitals. To date,Mu Mian Hua has opened eight branch clinics in Beijing, Guangzhou, Shenzhen, Xi’an, and Shantou, with additional branches in Shanghai, Tianjin, and other cities scheduled to open this year. The total gross floor area of its clinical facilities has reached 20,000 square meters, establishing a nationwide healthcare network covering South, North, East, and Northwest China.

Kapok deeply focuses on patient needs, with its services primarily centered on includingRecurrent Miscarriage, Repeated Implantation Failure in IVF, Diminished Ovarian Reserve, Refractory Endometrial Disorders, Endometriosis, Polycystic Ovary Syndrome...and other major challenges currently facing the field of reproductive health in China.

According to Mr. Lu Xiaohong, founder of the Kapok Reproductive Specialty Chain Clinics, although 2020 was a year marked by the pandemic, Kapok still completed 180,000 outpatient visits and provided diagnosis and treatment to 25,839 couples. It is expected that this year will see nearly 300,000 outpatient visits, with the number of couples treated exceeding 40,000, placing the clinic among the top in China.

According to Mr. Lu, the reason Mumianhua has achieved such results in a short period is mainly attributed to its team of doctors, which brings together many authoritative reproductive medicine experts from across China, as well as its cost-effective diagnosis and treatment services.

First and foremost is the team of renowned reproductive medicine specialists, which constitutes the core competitiveness of Mumianhua.Currently, Mumuhua has assembled numerous renowned reproductive specialists from Peking Union Medical College Hospital, Beijing Obstetrics and Gynecology Hospital of Capital Medical University, Dongzhimen Hospital of Beijing University of Chinese Medicine, three affiliated hospitals of Sun Yat-sen University, three affiliated hospitals of Guangzhou University of Chinese Medicine, the Third Affiliated Hospital of Guangzhou Medical University, and Guangdong Provincial Maternal and Child Health Hospital.

Among them, eight experts hold positions at the level of vice chairperson or higher in national academic societies, including one chairperson of a branch of the Chinese Medical Association, two deputy heads of the Gynecological Endocrinology Group under the Chinese Medical Association, and one vice chairperson of a branch of the Chinese Medical Doctor Association. Additionally, more than 35 experts serve as vice chairpersons or higher in provincial academic societies, making it a distinguished gathering of renowned physicians.

To build and cultivate a medical team of the highest professional caliber, Mumu Hua has focused its efforts on two key dimensions. One aspect involves inviting renowned experts in the field to join the platform. Mr. Lu told VCBeat, “The most critical factor for experts joining Mumu Hua is the alignment of values. First, Mumu Hua’s entire clinical care system is patient-centered, dedicated to providing the most professional diagnostic and treatment services. Second, rather than prioritizing profit, Mumu Hua returns to the essence of healthcare by focusing on therapeutic outcomes and helping patients resolve their health issues. Finally, Mumu Hua provides personalized support and refined services to experts, such as assigning clinical assistants and patient management teams, enabling them to concentrate more fully on delivering specialized care. Only in this way can patients receive an optimal consultation experience and achieve the best possible outcomes, fostering a healthy and virtuous ecosystem for the diagnosis and treatment of reproductive disorders.”

On the other hand, a comprehensive training system for specialist physicians should be established.According to Mr. Lu, more than half of the physicians at Mumianhua are outstanding young and middle-aged reproductive specialists who have been carefully selected and individually trained by the institution, providing a sustainable talent development pipeline for Mumianhua’s medical team. Currently, Mumianhua has cultivated nearly ten such physicians, each handling over 800 patient visits per month for the diagnosis and treatment of reproductive disorders. In addition, Mumianhua has established a dedicated Medical Department that organizes regular internal and external academic seminars and experience-sharing sessions for young and middle-aged physicians, enabling systematic study of clinical guidelines for reproductive diseases. The department regularly invites multidisciplinary experts in the field to deliver lectures and provide guidance, ensuring alignment with mainstream domestic concepts and cutting-edge academic advances. Physicians also engage in shadowing renowned reproductive specialists and conduct research on clinical issues under expert supervision. This multi-dimensional approach strengthens the specialized talent training system, continuously enhancing professional knowledge reserves and clinical practical skills.

Backed by top-tier medical expertise, the efficacy of treatments is firmly assured. Meanwhile, a comprehensive service system has significantly enhanced patients’ healthcare experience. Throughout, Mumuhua’s overall pricing remains highly affordable, generally on par with or comparable to that of Grade 3A hospitals.

Mr. Lu stated, “The consultation fees, laboratory test charges, and medication costs at Mumianhua are on par with or comparable to those at Grade 3A hospitals. However, Mumianhua not only maintains but also continuously enhances its service standards—for instance, by reducing patients’ waiting times for consultations and medication dispensing, and conducting regular follow-ups. The aim is to build a high-value healthcare service system that truly benefits patients.”

The integration of information technology into the healthcare sector is hardly a novel concept. With the rapid development and continuous optimization of emerging technologies, the efficient operational model of “Healthcare + IT” has become widely anticipated. This holds true for Mumianhua as well, where this key technology will continuously optimize the institution’s overall service system.

First, in terms of promotion.“Patient flow” is the lifeblood of private medical institutions; therefore, major offline healthcare providers have spared no effort in their marketing initiatives. Mumianhua is no exception. Leveraging online channels such as its official WeChat account, Xiaohongshu (Little Red Book), WeChat personal accounts, WeChat groups, and short-video platforms, it refines professional health education content with precision, accurately targets patients, and expands its user reach through a focused, ripple-effect strategy.

Secondly, in terms of service.Through the website and WeChat Official Account platforms, we have established a seamless online-to-offline service loop for patients. Personalized services—including appointment scheduling, remote consultations, free consultations, report inquiries, and medication delivery—have been fully implemented to comprehensively meet patients’ healthcare needs, ensuring timely access to medical care.

Then, in terms of examinations and tests.Currently, Mumuhua has established a strategic partnership with Sun Yat-sen University Daan Clinical Laboratory, jointly operating six local laboratories equipped with advanced diagnostic and testing equipment. These include the imported GE E8 high-end ultrasound system from the United States, the Roche chemiluminescence immunoassay analyzer from Switzerland, and the SCA semen analysis system from Spain, along with comprehensive blood testing panels for recurrent miscarriage. By introducing a variety of sophisticated, state-of-the-art devices, the partnership enables precise analysis of patients’ conditions, thereby facilitating the development of personalized treatment plans tailored to each patient’s needs.

Finally, regarding follow-up.Follow-up care is essential for healthcare institutions, as it not only improves treatment outcomes but also enhances patient retention—an area where public hospitals often fall short. At Mumuhua (Wood Cotton Flower), the institution has established a follow-up system that accurately tracks key metrics such as each physician’s return visit rate and first-visit attrition rate. Leveraging electronic medical records, it enables refined, personalized diagnosis and treatment based on patients’ real-time conditions. Additionally, Mumuhua assigns dedicated assistants to each physician to support them in delivering follow-up services to patients.

Since its inception, Mumu Flower has been committed to becoming a leading brand in the field of reproductive disorders in China. On this thorny path, Mumu Flower is well-prepared and has laid out its future strategic plans.

Mr. Lu provided a detailed explanation on how to quantify leading brands,“Leading brands in the field of reproductive disorders are generally evaluated across seven dimensions: first, clinical technical capability; second, outpatient visit volume; third, number of couples seeking consultation; fourth, number of families with reproductive disorders successfully treated; fifth, revenue scale; sixth, academic influence; and seventh, research strength.”

Along this path, Mumianhua has been making continuous efforts. According to Mr. Lu, Mumianhua currently ranks among the top in China across the first five dimensions, with future focus directed toward academic development and scientific research. In terms of research, Mumianhua has initiated the collection of clinical data on recurrent miscarriage from both traditional Chinese medicine and Western medicine gynecology practices. Regarding academic influence, Mumianhua will regularly hold academic conferences in collaboration with relevant domestic associations to better facilitate the rapid enhancement of academic research capabilities among young and middle-aged physicians.

In terms of specific business directions, Mumuhua also demonstrates innovative thinking. Mr. Lu stated, “The ‘three-child policy’ has brought certain benefits to the reproductive health market, but Mumuhua is more focused on”The Diagnostic and Treatment Logic Behind Reproductive Disorders and Unmet Patient Needs“The three-child policy will inevitably lead to a significant increase in the number of women of advanced maternal age. With advancing age, fertility declines, the risk of adverse pregnancy outcomes rises, and obstetric complications become more frequent. Therefore, reducing reproductive risks for these women and offering them ‘hope for childbirth’ will be a key focus area for Woodpecker Clinic in the future.”

Specifically, comprehensive support will be provided for women with reproductive disorders from the following three aspects:First, implement refined management during the preconception period. By integrating Traditional Chinese Medicine with Western medicine, significantly improve oocyte quality and overall physiological status, thereby increasing the likelihood of natural conception. Second, provide individualized diagnosis, treatment, and refined management. Develop personalized treatment plans based on patient medical history and comprehensive screening, with dynamic adjustments as needed. Utilize a digital management system for real-time monitoring of pregnant patients, offering immediate professional advice and regular follow-ups. Third, adopt a multidisciplinary team (MDT) approach to analyze reproductive barriers from multiple dimensions, addressing core issues precisely to provide optimal comprehensive treatment plans while prioritizing maternal and infant safety.

The Vision of Mumianhua: Ensuring Every Woman with Reproductive Challenges Has the Right to Become a Mother. This is destined to be a noble endeavor; therefore, Mumianhua will always maintain a sense of reverence, utilizing standardized processes, professional diagnosis and treatment, and compassionate care to help patients achieve successful conception and childbirth, enabling every woman to fulfill her dream of motherhood.